Qilu Pharmaceutical Breaks Ground on Global R&D Headquarters for Innovative Drugs in Zhangjiang

December 29,Qilu Pharmaceutical Global R&D Headquarters for Innovative DrugsThe groundbreaking ceremony was held in Zhangjiang Science City. Xu Lai, member of the Standing Committee of the Pudong New Area CPC Committee and Deputy District Chief of Shanghai, Director of Zhangjiang Science and Construction Office, and Director of Zhangjiang Administration BureauLeaders such as Xiao Jian attended the groundbreaking ceremony.

Xu Lai, Standing Committee Member of the Pudong New Area Committee and Deputy District Chief, pointed out that as the core and main承载area for the construction of Shanghai's international science and technology innovation center, Pudong New Area has become one of the regions with the most complete industrial chain and the most advanced innovative R&D in the biopharmaceutical field. The global R&D headquarters project for innovative drugs by Qilu Pharmaceutical willFocusing on cutting-edge fields such as oncology and autoimmune diseases, we aim to build a world-class new R&D platform.The completion of the project will become another significant milestone for Pudong to build a world-class biopharmaceutical industry cluster and contribute "Pudong strength" and the "China solution."

Li Yan, Deputy Secretary of the Party Committee and President of Qilu Pharmaceutical Group, stated that the global R&D headquarters project for innovative drugs by Qilu Pharmaceutical is based on the original mission of seeking revival for the nation, development for the industry, and health for the people. Biopharmaceuticals are crucial to China's economy, people's livelihood, and national security, connecting industrial development with public demand. The project willAdhering to the concepts of "innovation, intelligence, greenness, and humanity," we aim to build a highland for pharmaceutical research and create a scientific and humanistic home.